Nanotechnology in the treatment of infectious diseases

Adam Friedman, Karin Blecher Paz

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Nosocomial and community-acquired infections caused by multidrug-resistant (MDR) pathogens is rising at an alarming rate [1, 2]. Microbial resistance has developed as a result of the ease with which microorganisms can acquire and transfer antibiotic-resistant determinants as well as the inherent resistance in some species. In addition, the abuse of broad spectrum antibiotics has further influenced the development of antibiotic-resistant strains [3-6]. As a result, resistance to antibiotics and conventional therapies has become a public health threat resulting in increased patient morbidity and mortality, highlighting the need for novel approaches in the development of antimicrobial agents [7-9].

Original languageEnglish (US)
Title of host publicationNanotechnology in Dermatology
PublisherSpringer New York
Pages187-200
Number of pages14
Volume9781461450344
ISBN (Electronic)9781461450344
ISBN (Print)1461450330, 9781461450337
DOIs
StatePublished - Jul 1 2013

Fingerprint

Nanotechnology
Communicable Diseases
Anti-Bacterial Agents
Community-Acquired Infections
Microbial Drug Resistance
Anti-Infective Agents
Therapeutics
Public Health
Morbidity
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Friedman, A., & Blecher Paz, K. (2013). Nanotechnology in the treatment of infectious diseases. In Nanotechnology in Dermatology (Vol. 9781461450344, pp. 187-200). Springer New York. https://doi.org/10.1007/978-1-4614-5034-4_18

Nanotechnology in the treatment of infectious diseases. / Friedman, Adam; Blecher Paz, Karin.

Nanotechnology in Dermatology. Vol. 9781461450344 Springer New York, 2013. p. 187-200.

Research output: Chapter in Book/Report/Conference proceedingChapter

Friedman, A & Blecher Paz, K 2013, Nanotechnology in the treatment of infectious diseases. in Nanotechnology in Dermatology. vol. 9781461450344, Springer New York, pp. 187-200. https://doi.org/10.1007/978-1-4614-5034-4_18
Friedman A, Blecher Paz K. Nanotechnology in the treatment of infectious diseases. In Nanotechnology in Dermatology. Vol. 9781461450344. Springer New York. 2013. p. 187-200 https://doi.org/10.1007/978-1-4614-5034-4_18
Friedman, Adam ; Blecher Paz, Karin. / Nanotechnology in the treatment of infectious diseases. Nanotechnology in Dermatology. Vol. 9781461450344 Springer New York, 2013. pp. 187-200
@inbook{4b9fe921a762407f903f0018703a6a77,
title = "Nanotechnology in the treatment of infectious diseases",
abstract = "Nosocomial and community-acquired infections caused by multidrug-resistant (MDR) pathogens is rising at an alarming rate [1, 2]. Microbial resistance has developed as a result of the ease with which microorganisms can acquire and transfer antibiotic-resistant determinants as well as the inherent resistance in some species. In addition, the abuse of broad spectrum antibiotics has further influenced the development of antibiotic-resistant strains [3-6]. As a result, resistance to antibiotics and conventional therapies has become a public health threat resulting in increased patient morbidity and mortality, highlighting the need for novel approaches in the development of antimicrobial agents [7-9].",
author = "Adam Friedman and {Blecher Paz}, Karin",
year = "2013",
month = "7",
day = "1",
doi = "10.1007/978-1-4614-5034-4_18",
language = "English (US)",
isbn = "1461450330",
volume = "9781461450344",
pages = "187--200",
booktitle = "Nanotechnology in Dermatology",
publisher = "Springer New York",

}

TY - CHAP

T1 - Nanotechnology in the treatment of infectious diseases

AU - Friedman, Adam

AU - Blecher Paz, Karin

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Nosocomial and community-acquired infections caused by multidrug-resistant (MDR) pathogens is rising at an alarming rate [1, 2]. Microbial resistance has developed as a result of the ease with which microorganisms can acquire and transfer antibiotic-resistant determinants as well as the inherent resistance in some species. In addition, the abuse of broad spectrum antibiotics has further influenced the development of antibiotic-resistant strains [3-6]. As a result, resistance to antibiotics and conventional therapies has become a public health threat resulting in increased patient morbidity and mortality, highlighting the need for novel approaches in the development of antimicrobial agents [7-9].

AB - Nosocomial and community-acquired infections caused by multidrug-resistant (MDR) pathogens is rising at an alarming rate [1, 2]. Microbial resistance has developed as a result of the ease with which microorganisms can acquire and transfer antibiotic-resistant determinants as well as the inherent resistance in some species. In addition, the abuse of broad spectrum antibiotics has further influenced the development of antibiotic-resistant strains [3-6]. As a result, resistance to antibiotics and conventional therapies has become a public health threat resulting in increased patient morbidity and mortality, highlighting the need for novel approaches in the development of antimicrobial agents [7-9].

UR - http://www.scopus.com/inward/record.url?scp=84949177572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949177572&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-5034-4_18

DO - 10.1007/978-1-4614-5034-4_18

M3 - Chapter

AN - SCOPUS:84949177572

SN - 1461450330

SN - 9781461450337

VL - 9781461450344

SP - 187

EP - 200

BT - Nanotechnology in Dermatology

PB - Springer New York

ER -